logo

For the Inventor, By the Inventor

Braunschweig, Germany

Armin Bauer

This inventor holds 4 USPTO granted patents. Top assignee: Novartis Ag. Active years: 1999-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Armin Bauer. Retrieved from https://idiyas.com/inventor/armin-bauer-oeknjtcl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 105(Granted Patents)


Location History:

  • Braunschweig, DE (1999 - 2000)
  • Frankfurt-am-Main, DE (2002)

Company Filing History:

goldMedal4 out of 3,978 
 
Novartis Ag
 patents

Years Active: 1999-2002

Loading Chart...
4 patents (USPTO):Explore Patents
1. 6350878 - Intermediates for the synthesis of epothilones and methods for their preparation (2002-02-26),
2. 6156905 - Deoxy epothilones and intermediates utilized in the process for (2000-12-05),
3. 6043372 - Intermediates in the process for preparing epothilones (2000-03-28),
4. 5969145 - Process for the production of epothilones and intermediate products (1999-10-19),

Title: Armin Bauer: Innovator in Pharmaceutical Chemistry

Introduction

Armin Bauer is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of epothilones. With a total of 4 patents to his name, Bauer's work has garnered attention for its potential applications in medicine.

Latest Patents

Bauer's latest patents include innovative processes and intermediates for the synthesis of epothilones. One of his key inventions is focused on deoxy epothilones and the intermediates utilized in their production. This invention relates to a process for producing epothilones and intermediate products, which are natural substances that can be produced by microorganisms. The taxols, which share similar properties, are of particular interest in pharmaceutical chemistry due to their therapeutic potential.

Career Highlights

Armin Bauer is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further his research and development efforts in the pharmaceutical sector. His contributions have been instrumental in advancing the understanding and application of epothilones in medicine.

Collaborations

Throughout his career, Bauer has collaborated with esteemed colleagues such as Dieter Schinzer and Anja Limberg. These collaborations have enriched his research and have led to significant advancements in the field.

Conclusion

Armin Bauer's innovative work in the synthesis of epothilones highlights his importance in pharmaceutical chemistry. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…